QXO heads into its August 13 earnings print with short sellers still retreating, borrow conditions loose, and the analyst community firmly on the bull side — yet the stock has given back ground since the previous preview, down 3.3% on Wednesday and 5.5% on the week to $15.03.
The short-covering trend flagged four days ago has continued. Short interest has fallen another 16.5% over the past week to 12.7% of the free float — down from above 20% of float in early July. The dramatic borrow squeeze of late June and early July, when availability collapsed to near zero and cost to borrow topped 5%, is now a distant memory. Availability has stabilised around 95%, cost to borrow has eased to 0.61%, and the lending market looks relaxed rather than stressed. Options positioning reinforces that picture: the put/call ratio is running at 0.28, near its 52-week low and slightly below its 20-day average, meaning call demand continues to dominate heading into the release.
The bull and bear cases are well-defined and genuinely contested. Bulls point to QXO's aggressive acquisition strategy — Beacon Roofing Supply and Kodiak Building Partners already folded in — and the company's stated goal of reaching $50 billion in annual revenues within a decade. Morgan Stanley reinstated coverage with an Overweight rating and a $35 target just nine days ago, the highest on the Street. The consensus sits at Buy, with a mean target around $29.80 — roughly double the current price. Bears counter that the valuation is demanding even on optimistic assumptions, with the bull case premised on an 18x EV/EBITDA multiple on pro-forma 2028 EBITDA that has yet to materialise. The ORTEX short score of 63.5 reflects residual bearish pressure despite the recent cover, and QXO's quality factor rank remains weak — negative return on assets and a low Altman Z-score keep balance-sheet sceptics engaged.
Institutional ownership adds one notable data point. Baillie Gifford added 34 million shares in the June quarter, a substantial new position for a long-only manager known for high-conviction growth bets. BlackRock added 21 million shares in the same period. Those are meaningful votes of confidence from patient capital — though they also represent potential sellers if the thesis is tested. Most peers closed lower on the week: FERG fell 3.9%, SITE dropped 5.3%, and WCC shed 2.3%, suggesting sector-level pressure rather than a QXO-specific selloff. Past earnings reactions have been consistently negative — the last four prints produced average five-day declines in the range of 4% to 14%.
The print will test whether QXO's integration progress and revenue trajectory justify the gap between a $15 stock and a $29 consensus target — and whether the short sellers who covered were early or simply right.
See the live data behind this article on ORTEX.
Open QXO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
